(Q44656714)
Statements
miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma (English)
Tae Hoen Kim
Ji-Ye Song
Ju-Yeon Jeong
A-Young Kwon
Jin Hyung Heo
Haeyoun Kang
Gwangil Kim
10 November 2014